Across TCGA pan-cancer cohorts, RN7SKP108 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RN7SKP108 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RN7SKP108 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SKP108 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

UCS, SKCM, and KIRC are the cancer types where RN7SKP108 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	III,IV	0.135	0.590	.048	36	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	18	view →
KIRC	DFS	Tertile	IV	0.217	0.603	.013	18	view →
STAD	DFS	Tertile	III,IV	0.867	0.311	.038	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RN7SKP108 tumor-vs-normal RNA expression · all RN7SKP108 data types